Boston Scientific Corp. (BSX.xnys) is a manufacturer of medical devices and healthcare equipment headquartered in Massachusetts, the United States. Boston Scientifics focuses on interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology, and gynecology. Through numerous acquisitions and mergers, Boston Scientific Corp. is among the top 50 medical devices manufacturers globally based on total revenue. It is traded on the New York Stock Exchange (NYSE) as a component of the Standard & Poor’s 500 Index (S&P-500), has a 31.000 workforce, and its current market cap is $62.69B (USD). With a high rate of reinvestment, albeit at a low return on equity, the company has managed to see considerable growth in its earnings. However, industry analyst forecasts reveal that Boston Scientific Corp. (BSX.xnys) earnings growth is expected to slow down.
Boston Scientific Corp (BSX)
Explore Boston Scientific Corp (BSX) share price analysis and trends to guide your trading strategy. Stay updated with FP Markets Germany for expert insights.